Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Stroke2Prevent
company
About
Stroke2Prevent is develops, manufactures and distributes medical devices.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Biotechnology,Health Care,Manufacturing,Medical Device
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Stroke2prevent B.V. develops, manufactures and distributes medical devices. Our product A-View is used to resolve the so called ‘blind-spot’ caused by interposition of the trachea in Transoesophageal Echocardiography (TEE). A-View provides images of of the entire thoracic aortic arch allowing detection of atherosclerosis, diagnosing aortic diseases and to permits monitoring of vascular flow. The additional information obtained by A-View supports physicians to ensure the best patient outcomes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Stroke2Prevent has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jun 30, 2016 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 30, 2016 | Series B | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Stroke2Prevent is funded by 1 investors.
DFZ Participaties
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
DFZ Participaties
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
